Genenta Science S.P.A.

Genenta Science’s passive insider filing shows board confidence amid a shift to Saentra Forge, offering investors a stable yet uncertain outlook.

Genenta Science’s insider filing shows no major share shifts as it pivots to Saentra Forge, aiming to diversify beyond oncology into biotech, defense, and aerospace.